Location History:
- Ile Des Soeurs, CA (2010 - 2011)
- Ile-des-soeurs, CA (2011)
- Montreal, CA (2009 - 2014)
- Verdun, CA (2006 - 2015)
Company Filing History:
5 out of 17 
1 out of 12 
1 out of 10 Years Active: 2006-2015
Title: Richard Beliveau: Innovator in Cancer Treatment
Introduction
Richard Beliveau is a notable inventor based in Verdun, Canada. With an impressive portfolio of 10 patents, he has dedicated his career to the development of innovative solutions in the field of medicine, specifically targeting cancer treatment and associated diseases.
Latest Patents
Among his latest inventions are significant advancements aimed at enhancing the potency of anticancer agents. One such patent, titled "Potentiation of Anticancer Agents," focuses on carriers, conjugates, and pharmaceutical compositions designed to increase the efficacy of drugs and modify pharmacokinetics. This innovation holds promise for improved treatment and diagnostic applications for cancer.
Another notable invention is the "Membrane Type-1 Matrix Metalloprotein Inhibitors and Uses Thereof." This patent stems from the discovery that a soluble polypeptide, featuring a nonphosphorylatable form of the MT1-MMP cytoplasmic domain, can inhibit MT1-MMP in a dominant negative manner. The compositions developed include peptide inhibitors and methods for treating diseases linked to MT1-MMP activity, such as cancer, arthritis, heart disease, and various vascular diseases.
Career Highlights
Throughout his career, Richard has significantly contributed to the pharmaceutical and biotechnology sectors. He has been affiliated with several reputable companies, including Angiochem Inc. and Raptor Pharmaceuticals Inc., where he utilized his expertise to propel advancements in therapeutic solutions.
Collaborations
Beliveau has collaborated with distinguished colleagues such as Michel Demeule and Christian Che. Their collective efforts have advanced research initiatives and fostered innovation in their shared fields of interest.
Conclusion
Richard Beliveau's work exemplifies the spirit of innovation and commitment to improving healthcare outcomes. His patents not only demonstrate his prowess as an inventor but also his dedication to tackling some of the most pressing health challenges facing society today. Through his inventions, he continues to pave the way for future research and development in cancer treatment and related therapeutic areas.